A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events.
Iyer SP et al. Br J Haematol. 2014 Aug 19. doi: 10.1111/bjh.13056. [Epub ahead of print].
Effect of Clodronate Treatment on Risk of Fracture: A Systematic Review and Meta-analysis.
Frediani B et al. Calcif Tissue Int. 2014 Aug 12. [Epub ahead of print].
A novel option for reducing free light chains in myeloma kidney: supra-hemodiafiltration with endogenous reinfusion (HFR).
Pasquali S et al. J Nephrol. 2014 Aug 23. [Epub ahead of print].
Miconazole mucoadhesive buccal tablet in high-dose therapy with autologous stem cell transplantation (HDT/ASCT)-induced mucositis.
Orvain C et al. Support Care Cancer. 2014 Aug 3. [Epub ahead of print]